Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Not available
- Industry
- Not available
- ISIN
- Not available
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- Not available
- MarketCapitalization
- Not available
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.
Visit company website
No comments yet
Start a focused discussion about PEARW.